UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2022 | 2023-02-06 | Future report Set alerts | |
| Q3 2022 | 2022-10-31 | 0.52 | 0.52 |
| Q2 2022 | 2022-08-01 | 0.70 | 0.70 |
| Q1 2022 | 2022-05-02 | 0.66 | 0.66 |
| Q4 2021 | 2022-02-07 | 0.77 | 0.77 |
| Q3 2021 | 2021-11-01 | 0.71 | 0.71 |
| Q2 2021 | 2021-08-02 | 0.66 | 0.66 |
| Q1 2021 | 2021-05-03 | 0.64 | 0.64 |
| Q4 2020 | 2021-02-08 | 0.76 | 0.76 |
| Q3 2020 | 2020-11-02 | 0.80 | 0.80 |
| 2015-09-11 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | |
| 2015-08-31 | Upgrade | Raymond James | Market Perform to Outperform | $48.00 |
| 2015-08-31 | Upgrade | Raymond James Financial Inc. | Market Perform to Outperform | $48.00 |
| 2015-01-20 | Downgrade | Monness Crespi & Hardt | Buy to Neutral | $40.00 to $45.00 |
| 2014-11-12 | Downgrade | Raymond James | Outperform to Market Perform | $40.00 |
| 2014-10-24 | Reiterated Rating | Monness Crespi & Hardt | Buy | $37.00 to $40.00 |
| 2014-09-22 | Upgrade | Raymond James | Market Perform to Outperform | $38.00 |
| 2014-07-07 | Boost Price Target | Monness Crespi & Hardt | Buy | $35.00 to $37.00 |
| 2014-04-23 | Boost Price Target | Haywood Securities | $2.00 to $11.00 | |
| 2014-01-21 | Upgrade | Monness Crespi & Hardt | Neutral to Buy | $35.00 |
| 2014-01-06 | Upgrade | Ned Davis Research | Neutral to Buy | |
| 2013-11-18 | Upgrade | Ned Davis Research | Neutral to Buy | |
| 2013-04-19 | Downgrade | Monness Crespi & Hardt | Buy to Neutral | |
| 2012-02-07 | Upgrade | Hilliard Lyons | Neutral to Long-term Buy | $28 |
| 2010-10-25 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2009-04-23 | Downgrade | Hilliard Lyons | Buy to Long-term Buy | $15 to $16 |
| 2009-02-04 | Reiterated | Hilliard Lyons | Buy | $20 to $15 |
| 2008-12-17 | Reiterated | Hilliard Lyons | Buy | $23 to $20 |
| 2008-08-25 | Upgrade | Stifel Nicolaus | Hold to Buy | $25 |
| 2007-12-04 | Downgrade | Morgan Keegan | Mkt Perform to Underperform | |
| 2007-10-15 | Initiated | Hilliard Lyons | Buy | $25 |
| 2007-01-29 | Downgrade | Longbow | Buy to Neutral |
| 2015-09-11 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | |
| 2015-08-31 | Upgrade | Raymond James | Market Perform to Outperform | $48.00 |
| 2015-08-31 | Upgrade | Raymond James Financial Inc. | Market Perform to Outperform | $48.00 |
| 2015-01-20 | Downgrade | Monness Crespi & Hardt | Buy to Neutral | $40.00 to $45.00 |
| 2014-11-12 | Downgrade | Raymond James | Outperform to Market Perform | $40.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In LEG 328 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| STATE STREET CORP | 16.42M |
| BlackRock Inc. | 15.12M |
| Vanguard Group, Inc | 12.95M |
| SCHWAB CHARLES INVESTMENT MANAGEMENT INC | 5.37M |
| BlackRock Fund Advisors | 5.17M |
| BlackRock Institutional Trust Company, N.A. | 3.76M |
| THOMASPARTNERS, INC. | 2.56M |
| DIMENSIONAL FUND ADVISORS LP | 2.01M |
| Epoch Investment Partners, Inc. | 1.87M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.74M |
| MORGAN STANLEY | 1.65M |
| OLD REPUBLIC INTERNATIONAL CORP | 1.36M |
| Invesco Ltd. | 1.19M |
| BlackRock Group LTD | 1.14M |
| NORTHERN TRUST CORP | 1.03M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| HAFFNER DAVID S Chief Executive Officer | 0.92% (1263073) | BMS / LEG / |
| GLASSMAN KARL G President & COO | 0.26% (352754) | LEG / REMY / |
| PARK DENNIS S Senior Vice President | 0.20% (277881) | LEG / |
| CRUSA JACK D Senior Vice President | 0.15% (204211) | LEG / |
| FISHER RICHARD T | 0.11% (144715) | LEG / |
| WEIL WILLIAM S Vice Pres - Corp Controller | 0.10% (141103) | LEG / |
| FLANIGAN MATTHEW C Executive Vice President - CFO | 0.09% (119927) | JKHY / LEG / |
| DAVIS PERRY E Senior Vice President | 0.08% (110117) | LEG / |
| DOLLOFF J MITCHELL Senior Vice President | 0.07% (94617) | LEG / |
| DOWNES JOSEPH D JR Senior Vice President | 0.06% (76313) | LEG / |
| DeSonier David M SVP-Strategy&InvestorRelations | 0.05% (68784) | LEG / |
| WOOD PHOEBE A | 0.05% (64165) | CCE / IVZ / LEG / PPL / PXD / |
| Iorio Russell J VP - Mergers & Acquisitions | 0.04% (61342) | LEG / |
| ODOM JUDY C | 0.04% (55053) | HHS / LEG / SABR / |
| CLARK RALPH W | 0.03% (46247) | LEG / |
| ENLOE ROBERT TED III | 0.03% (36854) | LEG / LYV / SLAB / |
| Brunner Robert E | 0.03% (36465) | LEG / LNN / NNBR / |
| MCCLANATHAN JOSEPH W | 0.02% (32933) | LEG / |
| Douglas Scott S SVP - General Counsel | 0.02% (32667) | LEG / |
| Moore John G. SVP - Chief Legal & HR Officer | 0.02% (28811) | LEG / |
| FERNANDEZ MANUEL A | 0.02% (21296) | BC / FLO / LEG / SYY / TIBX / TIME / |
| CULP ROBERT G III | 0.01% (18123) | CFI / LEG / ODFL / STLY / |
| TRENT TAMMY M VP - Chief Accounting Officer | 0.01% (12747) | LEG / |
UM